## AMP: Ameriprise Financial, Inc. - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 6.0% in lower entry zone (4.0-10.0%), top quartile (81st pct) cross-sectional ranking. Short-term MRS_5 (1.1%) confirms momentum alignment.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($466.90)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Neville Rodie & Shaw Inc. Takes Position in Ameriprise Financial, Inc. $AMP**
- Source: MarketBeat | 20251215T134652 | Somewhat-Bullish | Relevance: 95%
- Neville Rodie & Shaw Inc. has acquired a new stake of 2,608 shares in Ameriprise Financial, Inc. (NYSE:AMP) valued at approximately $1,281,000 during the 3rd quarter. Other institutional investors have also adjusted their holdings in Ameriprise Financial, and the company recently announced a quarterly dividend of $1.60 per share. Analyst ratings for AMP are mixed, with an average "Hold" rating and a price target of $533.22.

**2. Rich Steinmeier confides Commonwealth deal's big unseen cost -- the 'work' it took to keep its advisors -- while Osaic, Cetera, Raymond James and Kestra went to town recruiting during the time of distraction**
- Source: RIABiz | 20251217T032633 | Neutral | Relevance: 72%
- Rich Steinmeier, a key figure in the Commonwealth deal, has revealed the significant hidden cost to LPL: the extensive effort required to retain advisors. During this period of distraction for Commonwealth, other firms like Osaic, Cetera, Raymond James, and Kestra capitalized by aggressively recruiting new talent. This highlights the competitive pressures within the advisory community following major industry transactions.

**3. Thurston Springer Miller Herd & Titak Inc. Sells 1,881 Shares of Parker-Hannifin Corporation $PH**
- Source: MarketBeat | 20251217T140841 | Somewhat-Bullish | Relevance: 65%
- Thurston Springer Miller Herd & Titak Inc. significantly reduced its stake in Parker-Hannifin Corporation by 85.0% in Q3, selling 1,881 shares and retaining 331 shares valued at $251,000. Despite this, Parker-Hannifin exceeded quarterly expectations and issued strong FY2026 guidance, leading analysts to maintain a "Moderate Buy" rating with a $904.59 target price. However, recent insider selling, including by the COO and a VP, accounts for 7,432 shares sold in the last 90 days.

**4. WAVE Life Sciences (NASDAQ:WVE) Major Shareholder Purchases 1,470,000 Shares**
- Source: MarketBeat | 20251215T220851 | Somewhat-Bullish | Relevance: 65%
- GSK Plc, a major shareholder in WAVE Life Sciences (NASDAQ:WVE), recently purchased an additional 1,470,000 shares at $19.00 per share, totaling $27.93 million. This transaction increased GSK's stake by 8.76% to 18,245,691 shares. Despite negative earnings, analysts hold a "Moderate Buy" rating for WAVE Life Sciences with an average target price of $30.47.

**5. WaFd, Inc. (NASDAQ:WAFD) Given Consensus Rating of "Hold" by Brokerages**
- Source: MarketBeat | 20251217T110853 | Neutral | Relevance: 65%
- WaFd, Inc. (NASDAQ:WAFD) has received a consensus "Hold" rating from brokerages, with an average 12-month target price of $32.00, despite recent downgrades to "Sell" and reduced price targets from some analysts. The company's CEO recently doubled his stake in the company, and institutional investors hold a significant portion of the stock. WaFd also announced a quarterly dividend of $0.27 per share, yielding approximately 3.3%.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.05M) |
| Sells | 1 ($0.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.3% (-0.5%)
- JPMORGAN CHASE & CO: 10.3% (+53.2%)
- Blackrock Inc.: 9.7% (-5.2%)
- State Street Corpora: 4.8% (+0.4%)
- Geode Capital Manage: 3.1% (+0.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.75 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 60%, margin 20%). Balance sheet: strong liquidity (308.1x), $2.2B free cash flow. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $46.0B |
| Beta | 1.26 |
| 52W Range | $396.14 - $582.05 |
| Short Interest | 3.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.75 |
| Forward P/E | 11.7 |
| Current P/E | 12.7 |
| YoY Growth | 8.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at 6.0% (minimal 5-day change). Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 81st percentile. MRS_5 at 1.1% confirms short-term momentum alignment. AM_20 at 3.9% shows strong absolute momentum above own 20MA. Below SMA200 (0.99x), long-term trend not supportive. MACD histogram positive (2.93), confirming momentum. OFD pattern: +DUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.02% (CS: 81) | Strong |
| RSI_14 | 61.4 | Neutral |
| MACD Histogram | 2.93 | Bullish |
| vs SMA20 | 1.039x | Above |
| vs SMA50 | 1.040x | Above |
| vs SMA200 | 0.989x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $487.90
- **Stop Loss:** $466.90 (4.3% risk)
- **Target:** $519.40 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 51
- **Position Value:** $24,882.90
- **Portfolio %:** 24.88%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-01-28 (Est: $10.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.76 | $9.87 | +1.1% |
| 2025Q2 | $9.00 | $9.11 | +1.2% |
| 2025Q1 | $9.08 | $9.50 | +4.6% |
| 2024Q4 | $9.05 | $9.36 | +3.5% |

---
*RULE-based L3 | 2026-01-07 01:41 | MRS_20*